AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 159 |
Market Cap | 74.15B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 5.32 |
PE Ratio (ttm) | 30.89 |
Forward PE | n/a |
Analyst | Buy |
Ask | 170.69 |
Volume | 2,663,360 |
Avg. Volume (20D) | 2,484,704 |
Open | 166.42 |
Previous Close | 166.32 |
Day's Range | 161.58 - 166.92 |
52-Week Range | 144.80 - 200.53 |
Beta | undefined |
About ZTS
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respirat...
Analyst Forecast
According to 8 analyst ratings, the average rating for ZTS stock is "Buy." The 12-month stock price forecast is $220, which is an increase of 33.85% from the latest price.
Next Earnings Release
Analysts project revenue of $2.35B, reflecting a 6.19% YoY growth and earnings per share of 1.43, making a 15.32% increase YoY.
2 weeks ago · seekingalpha.com
Dividends Matter - 3 Of My Favorite Stocks In An Overpriced MarketThe market's lofty valuations make finding value tricky, but dividend stocks remain a beacon of stability and growth for long-term investors. I've identified three standout dividend stocks offering so...